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Pre-PTCA Post-PTCA P Cardiovascular Surgery
TLR = target lesion revascularization
Clinical events Native 1/3 yr SVG 1/3 yr Pvalue (log-rank)
Death (%) 0/1.5 8/22 0.0003
Q-wave MI (%) 1/1 5/8 0.06
TLR(%j 26/29 28/49 0.08
Non-TLR (%j 0/9 10/17 002
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To assess the late (3 years) clinical outcomes of JJIS stent (S) placement in
the treatment of native coronary(NC) and saphenous vein graft (SVG) lesions,
we compared baseline factors, procedural results and late clinical events in
112 pts (122 lesions) with native and 118 pts (153 lesions) with SVG lesions
treated with S at the Washington Hospital Center. Pts with SVG lesions were
older, had more frequent multivessel disease, history of prior MI, ostial and
denovo lesions and lower ejection fractions (all p < 0.005). The initial and final
% stenosis, procedural success and major complications (death, Q wave MI,
CABG) were similar between the 2 groups.
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Leukocyte depletion (LD) filters may be beneficial during reperfusion of
acutely ischemic myocardium; however, its role during cardiopulmonary
bypass (CPB) and blood cardioplegic (BCP) arrest is unknown. This study
sought to determine whether inserting LD filters during CPB and BCP arrest
decreased ischemic damage. In 20 pigs, the 2nd and 3rd diagonal vessels
were occluded for 90 minutes followed by 45 minutes of BCP arrest and 180
minutes of reperfusion on CPB. In 5 pigs, LD filters were inserted both in the
CPB and BCP circuits (CPB + BCP), 5 pigs had LD during BCP only (BCP). 5
pigs had LD during CPB only (CPB). and 5 pigs had no LD. Ischemic damage
was assessed by Wall Motion Scores IWMS) using 2-D echo (4 = normal to
-1 = dyskinesia) and the Area of Necrosis/Area of Risk (AN/AR). Results are
Mean ± SE.
Patients afflicted with aortic manifestations of the Marfan syndrome often
require staged aortic replacement. To facilitate anastomosing of the aorta
further downstream, the "elephant trunk technique", which leaves surplus
intravascular graft length, was applied.
Between 1982 and 1994, 18 elephant trunks were implanted in 14 patients
with the Marfan syndrome (age range 20-50 years) suffering from chronic
aortic dissection: type A = 9 (7 sip emergency repair in the acute stage).
type B = 5. In 5 patients, the primary elephant trunk was placed "proximally",
meaning the extension of a total aortic arch replacement into the proximal
descending thoracic aorta. It was left "distally", extending from a grafted de-
scending aorta into the thoraco-abdominal portion, in 9 patients. Subsequent
downstream replacement was performed after a mean interval of 9 months:
descending thoracic aortic replacement, again utilizing an elephant trunk, in
4 cases, thoraco-abdominal replacement in 5. Two patients undervvent ad-
ditional abdominal grafting. Thus, a total of 32 aortic operations, involving
18 elephant trunks, was performed in 14 patients. There was no mortality
associated with the elephant trunk technique. Over time, technical modifica-
tions were introduced to ease the unfolding of the trunk. Ample membrane
resection avoids its entrapment in the false lumen of a dissected vessel.
In patients with the Marfan syndrome, who often need multiple aortic op-
erations, the "elephant trunk technique" greatly disencumbers these trou-
blesome procedures.
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Comparative Analysis of Long Term Clinical
Outcomes After Native Coronary versus
Saphenous Vein Graft Stent Implantation
Angiographic % diameter stenosis
Reference lumen area (mm 2)
Lesion EEM area (mm2)
Stent area (mm2)
Lesion lumen area (mm2)
Lesion plaque area (mm2)
IH area within stent (mm2)
% Area stenosis lumen vs reference
% Area stenosis stent vs reference
Pre-intervention, 80% of lesions had a minimum stent area less than the
reference lumen area, compared to 50% post-PTCA (p = 0.0028). Impor-
tantly, 55% of lumen enlargement after repeat PTCA was the result of addi-
tional stent expansion and 45% was the result of extrusion of tissue through
the stent (decreased IH area within the stent). There was no evidence of
compression of neointimal tissue post-PTCA (no change in overall plaque
area). Dissections were uncommon (occurring in 17% of lesions after PTCA)
and were minor in nature without clinical consequences. We Conclude: In-
stent restenosis appears to be the result of inadequate primary stent ex-
pansion and superimposed neointimal hyperplasia. The mechanism of suc-
cessful PTCA of in-stent restenosis is a combination of additional stent ex-
pansion (increased stent area) and neointimal tissue extrusion through the
stent. PTCA of in-stent restenosis results in a relatively high residual steno-
sis langiographic % diameter stenosis = 17 ± 11 and ultrasound % area
stenosis = 31 ± 22); this may contribute to more frequent repeat episodes
of restenosis.
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We conclude that LD filters significantly reduce ischemic damage and are
most effective when placed in the CPB circuit.
*p < 0.05 from no LD and BCP groups
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(repeat PTCA or CABG) and EFS = event free survival (freedom from death,
Q-wave MI, and TLR). During the first year after S placement, SVG lesions
(compared with NC) had higher mortality and Q-wave MI. similar TLR and
greater non-TLR events. Between 1 and 3 years, in SVG pts there was a fur-
ther dramatic increase in mortality and TLR resulting in a 3-year actuarial EFS
of only 37% (see figure). In contrast, NC behavior was stable between 1 and
3 years with no further mortality, Q-wave MI, or TLR, but a 10% incidence
of non-TLR events. In conclusion: Despite similar procedural results, SVG vs
native pts treated with S manifested disparate late clinical responses. Dis-
turbingly, in SVG pts there was progressive mortality(in part due to increased
pt morbidity) and additional TLR events after the first year of S implantation
(ie. "late" restenosis) causing a striking attrition in 3 year EFS.
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Between 6/79 and 6/93 a total of 560 patients with mitral insufficiency had
Carpentier type mitral valve reconstruction with ring annuloplasty. The pri-
mary etiology of mitral disease was degenerative in 46%, rheumatic in 21 %,
ischemic in 18% and other in 15%. Concomitant cardiac procedures were
performed in 283 patients (51 %). Hospital mortality was 5.9% 133/560) over-
all and 2.5% (7/277) for isolated mitral reconstruction. Multivariate anal-
ysis revealed that NYHA classification, age, and associated coronary dis-
ease were significant predictors of increased operative risk. Late clinical and
echocardiographic follow-up (f/u) was 98% complete, with a mean flu inter-
val of 3.5 years (range 1 month-14 years; total flu 1,977 patient-years). Actu-
arial freedom from complications at 5 and 10 years was as follows: throm-
boembolic = 93% &86%, anticoagulant ~ 97% &97%, endocarditis = 97%
